Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

497
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
497
Other Disorders of Digestive System01:30

Other Disorders of Digestive System

1.3K
The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...
1.3K
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

700
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
700
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

879
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
879
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

640
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
640
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

1.0K
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

"It's My Wish, We Need This Program": Qualitative Reflections From People With High-Grade Brain Cancer Consenting to Postmortem Brain Donation.

JCO oncology practice·2025
Same author

"I'm standing next to him, I'm supporting him"-Supporting a loved one with brain cancer to donate their brain: A qualitative study.

Neuro-oncology practice·2024
Same author

'I think both of us drew strength from it': qualitative reflections from next of kin following the death and post-mortem brain donation of a loved one with brain cancer.

Palliative care and social practice·2024
Same author

Coeliac disease is a strong risk factor for Gastro-oesophageal reflux disease while a gluten free diet is protective: a systematic review and meta-analysis.

EClinicalMedicine·2024
Same author

A Minority of Childhood Disorders of Gut-Brain Interaction Persist Into Adulthood: A Risk-Factor Analysis.

The American journal of gastroenterology·2024
Same author

Understanding the value of brain donation for research to donors, next-of-kin and clinicians: A systematic review.

PloS one·2023
Same journal

Needle-based confocal laser endomicroscopy and artificial intelligence in pancreatic cystic lesions: Insights and clinical advances.

Best practice & research. Clinical gastroenterology·2026
Same journal

Evidence-based approach to the diagnosis, management and surveillance of pancreatic cystic lesions: from the guidelines to the clinical practice.

Best practice & research. Clinical gastroenterology·2026
Same journal

Pancreatic cystic lesions in hereditary syndromes: Diagnostic role of endoscopic ultrasound.

Best practice & research. Clinical gastroenterology·2026
Same journal

Predictive risk models for the diagnosis and cancer progression of pancreatic cysts.

Best practice & research. Clinical gastroenterology·2026
Same journal

Preface.

Best practice & research. Clinical gastroenterology·2026
Same journal

Endoscopic ultrasound-guided treatment of pancreatic lesions.

Best practice & research. Clinical gastroenterology·2026
See all related articles

Related Experiment Video

Updated: Jan 6, 2026

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
06:40

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management

Published on: June 29, 2019

6.9K

Tangible pathologies in functional dyspepsia.

Marjorie M Walker1, Michael D Potter1, Nicholas J Talley2

  • 1Faculty of Health and Medicine, University of Newcastle, HMRI Building, Kookaburra Circuit, New Lambton Heights, 2305 NSW, Australia; School of Medicine & Public Health, University of Newcastle Callaghan 2308, NSW Australia; Australian Gastrointestinal Research Alliance, University of Newcastle, NSW, Australia.

Best Practice & Research. Clinical Gastroenterology
|October 10, 2019
PubMed
Summary
This summary is machine-generated.

Functional dyspepsia (FD) is a complex disorder defined by symptoms, but emerging evidence reveals underlying pathologies like duodenal changes and infections. Identifying these causes may lead to more effective targeted treatments for FD patients.

Keywords:
AtopyAutoimmuneDysbiosisDysmotilityEosinophilFunctional dyspepsiaGeneticsPathologyTherapy

More Related Videos

Author Spotlight: Reliable and Reproducible In Vitro Assessment of Drug Impact on Rat Intestinal Tubes
06:01

Author Spotlight: Reliable and Reproducible In Vitro Assessment of Drug Impact on Rat Intestinal Tubes

Published on: July 26, 2024

988
Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.4K

Related Experiment Videos

Last Updated: Jan 6, 2026

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
06:40

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management

Published on: June 29, 2019

6.9K
Author Spotlight: Reliable and Reproducible In Vitro Assessment of Drug Impact on Rat Intestinal Tubes
06:01

Author Spotlight: Reliable and Reproducible In Vitro Assessment of Drug Impact on Rat Intestinal Tubes

Published on: July 26, 2024

988
Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.4K

Area of Science:

  • Gastroenterology
  • Pathophysiology
  • Neurogastroenterology

Background:

  • Functional dyspepsia (FD) is a prevalent gastrointestinal disorder characterized by abdominal pain and meal-related symptoms.
  • Current definitions rely on symptom-based criteria (Rome consensus), with subtypes including postprandial distress syndrome and epigastric pain syndrome.
  • Traditionally considered without identifiable pathology, FD is increasingly recognized to involve underlying pathophysiological changes.

Purpose of the Study:

  • To review the evolving understanding of functional dyspepsia.
  • To highlight the recognition of tangible pathologies in FD.
  • To explore potential triggers and future therapeutic avenues for FD.

Main Methods:

  • Literature review of Rome consensus criteria for functional bowel disorders.
  • Analysis of epidemiological studies on FD triggers.
  • Examination of emerging research on duodenal pathologies and brain-gut interactions in FD.

Main Results:

  • FD encompasses symptom-based definitions but also involves significant pathologies such as Helicobacter pylori infection, duodenal eosinophilia, altered permeability, neuronal changes, and microbial dysbiosis.
  • Epidemiological data suggest allergy, immune disorders, and infection as potential triggers for FD.
  • Brain-gut/gut-brain axis disorders, including anxiety and depression, are associated with FD.

Conclusions:

  • Functional dyspepsia is increasingly viewed as a distinct disease entity with identifiable underlying pathologies.
  • Recognition of these pathologies offers a pathway toward developing targeted and more effective treatments for FD.
  • Further research into duodenal pathology and brain-gut interactions is crucial for advancing FD management.